Plain-English translation of NCT06781151 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study is testing whether analyzing the genetic makeup of your cancer tumor — combined with advice from a team of cancer specialists — can help doctors choose the best personalized treatment for you. If you have recurrent ovarian, cervical, or endometrial cancer, your tumor tissue will be sent for genetic sequencing to identify what's driving your cancer. A team of experts will then use those results to recommend a treatment strategy tailored specifically to your cancer.
When gynecological cancers come back after initial treatment, doctors often struggle to find the right next step. This study exists to see whether personalized treatment plans based on your tumor's genetics — rather than a one-size-fits-all approach — can help more patients respond to therapy and improve outcomes.
You likely qualify if…
You likely don't qualify if…
You will have tumor tissue and blood samples collected for genetic testing. A team of cancer specialists will review your test results and medical history to design a personalized treatment recommendation for you. Your doctor will then decide on your final treatment plan, taking into account the specialist recommendations along with your preferences, other health conditions, and practical factors like insurance coverage. The study will follow your treatment outcomes to see whether this personalized approach helps your cancer respond.
AI-generated summary from trial data · Jun 28, 2026 · Not medical advice
China